Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer
- PMID: 33989264
- DOI: 10.1097/SHK.0000000000001665
Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer
Conflict of interest statement
The author reports no conflicts of interest.
Comment on
-
Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.Shock. 2021 Mar 1;55(3):316-320. doi: 10.1097/SHK.0000000000001635. Shock. 2021. PMID: 32769822 Free PMC article.
References
-
- Levi M, Hunt BJ. Thrombosis and coagulopathy in COVID-19: an illustrated review. Res Pract Thromb Haemost 4 (5):744–751, 2020.
-
- Nougier C, Benoit R, Simon M, Desmurs-Clavel H, Marcotte G, Argaud L, David JS, Bonnet A, Negrier C, Dargaud Y. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J Thromb Haemost 18 (9):2215–2219, 2020.
-
- Blasi A, von Meijenfeldt FA, Adelmeijer J, Calvo A, Ibañez C, Perdomo J, Carlos Reverter J, Lisman T. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation. J Thromb Haemost 2020; doi: 10.1111/jth.15043. - DOI
-
- Thachil J, Srivastava A. SARS-2 coronavirus–associated hemostatic lung abnormality in COVID-19: is it pulmonary thrombosis or pulmonary embolism? Semin Thromb Hemost 46 (7):777–780, 2020.
-
- Creel-Bulos C, Auld SC, Caridi-Scheible M, Barker N, Friend S, Gaddh M, Kempton CL, Maier C, Nahab F, Sniecinski R. Fibrinolysis shutdown and thrombosis in a COVID-19 ICU. Shock 55 (3):316–320, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
